• | home
  • | corporate
  • | investors
  • | products
  • | clinical trials
  • | partnering
  • | contact
TSX: HBP - NYSE Amex: HBP - Frankfurt: HBP

Stock Quote
  • | Overview
  • | Corporate Governance
    • | Board Mandate
    • | Board Committee Charters
    • | Whistleblowing Policy
    • | Code of Conduct
  • | Investor Fact Sheet
  • | News Releases
    • | Fiscal 2012
    • | Archive
  • | Financial Statements
    • | Fiscal 2012
    • | Archive
  • | Annual Reports
  • | Regulatory Filings
  • | Analyst Coverage
  • | Presentations
    • | Corporate Presentations
    • | Scientific Presentations
  • | FAQ Investor Relations
  • | Stock Quote
  • | Shareholder Services
  • | Email Alerts
  • | Legal Disclaimer
  • | Contact IR

Stock Quote

Helix is a publicly listed biopharmaceutical company, with its common shares listed on the Toronto Stock Exchange and the NYSE Amex under the trading symbol “HBP”. The Corporation is also listed on the Frankfurt stock exchange (WKN 918864) and quoted on the Munich, Stuttgart and Berlin exchanges. Click below to find a link to the corresponding exchange.

Toronto Stock Exchange: HBP

NYSE Amex: HBP

German Stock Exchanges: HBP
 



  • | home
  • | site map
  • | privacy
  • | terms of use / disclaimers
  • | polski
  • | login
© Helix BioPharma Corp.